LONDON, January 11 /PRNewswire/ -- eyeforpharma, the global source of information and education for the pharmaceutical industry, announced today that the 5th annual Patient Compliance & Communication conference, London, 11-12 June 2008 has secured its full speaker faculty including leading executives from Pfizer, Novartis, Wyeth, GSK, Bayer, AstraZeneca and Merck Serono.
The full detailed brochure is available to download now at http://www.eyeforpharma.com/pceu2008/brochure.shtml
The conference will comprise a carefully selected faculty of speakers, ranging from Big Pharma like Pfizer to payers, patient advocacy groups, nurses, pharmacists and other important stakeholders. Keynotes include Bernd Majentry, Head of Brand RoI, Bayer Healthcare; Keith Allan, Head of Advocacy, Novartis; Kaush Gandhi, Brand Manager EMEA, Embrel Consumer Marketing, Wyeth; Manos Papadakis, Brand Manager, GSK; Murat Tanoren, Product Manager, Pfizer; Wendy Clyne, Assistant Director: Medicines Partnership Programme, National Prescribing Centre; Steve Mott, CEO ,Medicines.org.uk; Senior Representative, Lloyds Pharmacy
Manos Papadakis, a Brand Manager of Cervix at GlaxoSmithKline comments that "This is the perfect opportunity for brand managers from across Europe to gather and discuss the implications of the rapidly advancing patient compliance & communications area on our products. I envisage it could be one of the defining features of success in the near future, though of course nothing is certain."
The two day event taking place June 11-12 2008, London, comprises presentation sessions, roundtables, workshops, a networking evening and an exhibition hall. Some of the topics to be explored at the Summit are how patient compliance programmes can add value to a brand's offerings in the marketplace, thus helping it gain reimbursement, fight generics and differentiate against other brands. Experts will also look at how to measure the financial RoI of compliance & communication programmes, how to understand and influence patient behaviour, how to work more effectively with key stakeholders, leveraging new media and multi-channel communications, and taking advantage of scalable technological solutions.
Keith Allan, Global Head of Advocacy at Novartis says that "I am involved with this conference because I believe we need to develop meaningful connections between the industry, stakeholders and patients. Patient Compliance offers an exceptional chance to achieve something rare: a Win-Win-Win scenario where patient get better, they therefore save payers money by not regressing, and of course this aid's the reputation of a company or brand. And it allows us to work meaningfully with Patient Advocacy groups and other stakeholders to achieve this result."
eyeforpharma is offering Early Bird discounts to those who secure their place at the Summit early, with EUR300 knocked off the price of tickets to anyone registering before February 20th, making the cost EUR1395 for a full Silver Pass. In the interest of encouraging stakeholders such as patient advocacy groups to join in the debate, eyeforpharma are wiling to offer cost-price passes to the community to the event. To enquire about this, contact the event Director, Mark Walker (details below).
Further updates, full information on presentations and speakers, and details on other ticket options can all be found by downloading the brochure at http://www.eyeforpharma.com/pceu2008/brochure.shtml
eyeforpharma is a leading global source of information for the pharmaceutical industry. Our reputation has been built on quality, in-depth conferences that have distinguished themselves from competitors by the depth and breadth of research we put into each conference to ensure it is covering the hottest and most pertinent issues of the industry. Months are spent talking directly to senior executives in the industry, as well as relevant consultants and journalists and well respected solutions providers.
eyeforpharma also provides a fortnightly newsletter to over 11 thousand leading executives from every major pharmaceutical company in the industry, and of course consultants, sponsors and academics as well.
The eyeforpharma wiki, launched last month, highlights our dedication to improving the communication between people in the industry and furthering learning and development within it.
Please visit http://www.eyeforpharma.com to find out more about us.